Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
Julia Owens, Chief Executive Officer at Basking Biosciences Inc, reposted from Basking Biosciences, Inc. on LinkedIn:
”Stroke remains one of the world’s leading causes of death and disability — and the numbers continue to rise.
This underscores why advancing new treatments is so critical.
For women, the risk is even higher, and symptoms can present differently — fatigue, nausea or confusion can be easy to overlook.
Recognizing the signs early and improving access to timely care remain essential to changing outcomes.
These are the realities that drive each of us at Basking to keep pushing for better treatments.”
Quoting Basking Biosciences, Inc.‘s post”
”Stroke remains the second leading cause of death and the third leading cause of death and disability combined, accounting for more than 160 million disability-adjusted life years (DALYs) worldwide.
Between 1990 and 2021, the global impact of stroke has grown substantially — incident strokes increased by 70%, deaths by 44%, and DALYs by 32%, with the majority of this burden (87% of deaths and 89% of DALYs) falling on low- and middle-income countries.
In 2019, the global cost of stroke exceeded US$964 billion annually and is projected to reach US$2 trillion by 2050, with long-term disability as the largest driver of economic and social burden.
These staggering statistics underscore the critical need for new therapeutic options that can expand access to timely treatment, improve outcomes and ultimately redefine how stroke is treated worldwide.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series